Tag: corporation

ATLANTA, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Atlantic American Corporation (Nasdaq- AAME) today reported net income of $3.3 million, or $0.15 per diluted share, for the three month period ended June 30, 2025 compared to net loss of ($0.7) million, or ($0.04) per diluted share, for the comparable period in 2024. The Company had net income of $4.1 million, or $0.19 per diluted share, for the six month period ended June 30, 2025, compared to net loss of ($2.7) million, or ($0.14) per diluted share, for the six month period ended June 30, 2024. The increase in net income for the three month and six month periods ended June 30, 2025 was primarily the result of increases in premium revenue, coupled with an increase in unrealized gains on equity securities.

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Surgical Instrument Tracking Market size & share revenue was valued at approximately USD 74.48 Million in 2024 and is expected to reach USD 83.25 Million in 2025 and is expected to reach around USD 226.61 Million by 2034, at a CAGR of 11.78% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Vizinex (HID Global Corporation), Fortive Corporation, Becton Dickinson and Company (BD), Steris, Integra LifeSciences Corporation, Censis, Surlogs, Stryker, Medtronic, B. Braun SE, Olympus Corporation, Case Medical, Scanlan International, Inc., Securitas Healthcare LLC and others.

GUELPH, Ontario, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Current Water Technologies Inc. (TSX-V: WATR) ("CWTI" or "the Company" or "the Corporation"), is pleased to provide an update to its March 17, 2025 press release. Fabrication of the electrochemical water treatment system followed by a comprehensive in-house test program has been completed. The system is scheduled to be shipped to the client within the next 1-2 weeks.

BALA CYNWYD, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.